The Blood Typing Market was valued at USD 2.12 Billion in 2024, and is projected to reach USD 3.47 Billion by 2030, rising at a CAGR of 8.61%. This growth is fueled by the increasing usage of blood group typing in forensic sciences and prenatal testing, alongside the rising number of blood transfusions necessitated by road accidents and emergencies.
Blood group typing is a critical process that identifies the O, A, B, and AB groups, ensuring compatibility between donors and recipients and determining the Rh factor. This is particularly crucial in prenatal testing to prevent Hemolytic Disease of the Newborn (HDN), a condition that can be fatal if not detected. The market's growth is also supported by the growing number of road accidents and emergencies, which necessitate transfusions, and the increasing number of donations.
According to CDC, road accidents claim approximately 1.35 million lives annually, highlighting the critical role of blood group typing in ensuring safe transfusions. The advanced medical infrastructure in many countries, including increased storage capacities in hospitals, further supports the market's growth by facilitating the storage and availability of blood samples for typing and cross-matching. The rise in accidents and trauma cases requiring blood transfusions is another key factor for the market growth. The urgent need for transfusion in patients requiring surgical intervention also acts as a key driving factor.
Furthermore, prenatal testing, which requires blood group typing to manage potential complications, is another significant driver. The need for accurate blood group typing in pregnant women to prevent HDN is anticipated to further drive the market's growth. In addition, the increasing demand for blood group typing in forensic sciences contributes to the market’s expansion.
Moreover, market players are striving to innovate and introduce new initiatives that contribute to the advancement of diagnostic technologies. These initiatives play a pivotal role in shaping the dynamics of the market, driving improvements in patient care, and addressing the evolving needs of healthcare providers. By leveraging their expertise and resources, market players introduce innovative solutions that enhance efficiency, accuracy, and accessibility within the healthcare ecosystem. For instance, in March 2022, Quotient Limited obtains CE Mark for MosaiQ Extended Immunohematology Microarray, enhancing blood typing capabilities with Antibody Screening, Antigen Typing, and ABO grouping on a single platform, promising improved workflow and clinical value. Such initiatives market players contribute to the broader healthcare market, with a focus on advancements in diagnostic technologies.
This product will be delivered within 2 business days.
Blood group typing is a critical process that identifies the O, A, B, and AB groups, ensuring compatibility between donors and recipients and determining the Rh factor. This is particularly crucial in prenatal testing to prevent Hemolytic Disease of the Newborn (HDN), a condition that can be fatal if not detected. The market's growth is also supported by the growing number of road accidents and emergencies, which necessitate transfusions, and the increasing number of donations.
According to CDC, road accidents claim approximately 1.35 million lives annually, highlighting the critical role of blood group typing in ensuring safe transfusions. The advanced medical infrastructure in many countries, including increased storage capacities in hospitals, further supports the market's growth by facilitating the storage and availability of blood samples for typing and cross-matching. The rise in accidents and trauma cases requiring blood transfusions is another key factor for the market growth. The urgent need for transfusion in patients requiring surgical intervention also acts as a key driving factor.
Furthermore, prenatal testing, which requires blood group typing to manage potential complications, is another significant driver. The need for accurate blood group typing in pregnant women to prevent HDN is anticipated to further drive the market's growth. In addition, the increasing demand for blood group typing in forensic sciences contributes to the market’s expansion.
Moreover, market players are striving to innovate and introduce new initiatives that contribute to the advancement of diagnostic technologies. These initiatives play a pivotal role in shaping the dynamics of the market, driving improvements in patient care, and addressing the evolving needs of healthcare providers. By leveraging their expertise and resources, market players introduce innovative solutions that enhance efficiency, accuracy, and accessibility within the healthcare ecosystem. For instance, in March 2022, Quotient Limited obtains CE Mark for MosaiQ Extended Immunohematology Microarray, enhancing blood typing capabilities with Antibody Screening, Antigen Typing, and ABO grouping on a single platform, promising improved workflow and clinical value. Such initiatives market players contribute to the broader healthcare market, with a focus on advancements in diagnostic technologies.
Blood Typing Market Report Highlights
- Reagents and consumables led the product & services segment and accounted for 71.4% of the global revenue in 2024 and is anticipated to grow at lucrative growth over the forecast period, owing to extensive R&D initiatives being undertaken by major players for development of novel kits
- Based on test type, Antibody Screening led the test segment with a market share of 38% in 2024 due to the growing volume of prenatal testing, increasing transfusions and rising prevalence of chronic diseases, whereas HLA typing segment is estimated to grow at the fastest CAGR over the forecast period, owing to the development of advanced and innovative diagnostics in the market
- Based on technique, PCR-based and Microarray-based led the technique segment with a market share of 53.2% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period
- Based on application, diagnostic testing dominated the application segment with a market share of 54.2% in 2024. The organ transplants segment is estimated to grow at the fastest CAGR over the forecast period
- Based on end-use, the Diagnostic laboratories dominate the end use segment with a market share of 43.4% in 2024, owing to large number of tests being done at the facilities
- North America dominated the market with the revenue share of 42.83% in 2024, owing to factors such as advanced healthcare infrastructure, rising prevalence of chronic diseases, and favorable regulatory environment
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Blood Typing Market Variables, Trends & Scope
Chapter 4. Blood Typing Market: Product & Services Estimates & Trend Analysis
Chapter 5. Blood Typing Market: Test Estimates & Trend Analysis
Chapter 6. Blood Typing Market: Technique Estimates & Trend Analysis
Chapter 7. Blood Typing Market: Application Estimates & Trend Analysis
Chapter 8. Blood Typing Market: End-use Estimates & Trend Analysis
Chapter 9. Blood Typing Market: Regional Estimates & Trend Analysis by Product & Services, Test, Technique, Application and End-use
Chapter 10. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this Blood Typing market report include:- Mesa Laboratories, Inc. (Agena Bioscience, Inc.)
- Danaher Corporation (Beckman Coulter)
- Bio-Rad Laboratories, Inc.
- DIAGAST
- Grifols, S.A.
- AXO Science
- Merck KGaA
- Quotient, Ltd.
- Thermo Fisher Scientific
- Immucor, Inc.
- BAG Diagnostics GmbH
- Seegene Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.12 Billion |
| Forecasted Market Value ( USD | $ 3.47 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
